|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Medtecs International Corporation Ltd
Main Activities: Miscellaneous Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Medtecs International Corporation Ltd Headquarters #04-00, Malacca Centre 20 Malacca Street; Singapore; Singapore; 048979 Legal Address Clarendon House, 2 Church Street; Hamilton ; Hamilton; HM 11 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : BMG5958R1043 Financial Auditors: Sycip Gorres Velayo & Co (2002) Incorporation Date: November 26, 1997 Total Employees: 3,273 Tel: (632) 8179000 |
|
Company Description |
| The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. The Group also acts as agent to distribute other branded medical devices in Asia Pacific. Medtecs International Corporation Ltd is an integrated healthcare products and services provider in Asia Pacific, and a leading manufacturer and distributor of medical consumables for the global | ||
|
||
Company Analysis |
| According to the Consolidated - Audited financial statement for the Year of 2010, total net operating revenues decreased with -21.30%, from USD 57,420 thousands to USD 45,187 thousands. Operating result decreased from USD 4,060 thousands to USD 3,066 thousands which means -24.48% change. The results of the period decreased -35.07% reaching USD 1,381 thousands at the end of the period against USD 2,127 thousands last year. Return on equity (Net income/Total equity) went from 4.42% to 2.72%, the Return On Asset (Net income / Total Asset) went from 2.08% to 1.22% and the Net Profit Margin (Net Income/Net Sales) went from 3.70% to 3.06% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 117.62% compared to 107.25% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.67 to 1.24 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
| SELECT CURRENCY |
| Figures in: USD | EUR |
|
2010 Y (cons) |
2010 Q2C (cons) |
|
 | ||
| Audited | Non-Audited | |
| ||
| CEIC Company Financials (New) | CEIC Company Financials (New) | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
113,211 |
106,795 |
| ||
Current Assets |
55,727 |
54,738 |
| ||
Total Liabilities |
59,762 |
55,543 |
| ||
Shareholders Equity |
53,449 |
51,252 |
| ||
Current Liabilities |
44,849 |
38,614 |
| ||
| * All the accounts are in USD. | ||
Income Statement
| ||
Total Operating Revenue |
45,962 |
21,970 |
| ||
Operational Profit (Loss) |
3,066 |
1,331 |
| ||
Net Profit (Loss) |
1,401 |
705 |
| ||
| * All the accounts are in USD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
1.22% |
0.71% |
| ||
Annualised Return on Assets (ROA) |
1.22% |
1.42% |
| ||
Return on Equity (ROE) |
2.72% |
1.55% |
| ||
Annualised Return on Equity (ROE) |
2.72% |
3.1% |
| ||
Return on Sales (ROS) |
6.83% |
6.18% |
| ||
Return on Capital |
2.05% |
1.03% |
| ||
Gross Profit Margin |
22.32% |
21.46% |
| ||
Operating Profit Margin |
3.1% |
3.27% |
| Efficiency Ratios | ||
| ||
Inventory Turnover |
0.01x |
0.01x |
| ||
Current asset turnover |
0.01x |
0.00x |
| ||
Fixed-asset turnover |
0.01x |
0.00x |
| ||
Asset Turnover |
0.00x |
0.00x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
3,084 |
1,331 |
| ||
EBITDA |
7,814 |
3,342 |
| ||
Enterprise value |
90,704 |
85,389 |
| ||
Enterprise Value / EBITDA |
11.61 |
25.55 |
| ||
Bookvalue (BV) |
50,808 |
48,705 |
| ||
Net Cash |
1,560 |
4,436 |
| Liquidity Ratios | ||
| ||
Current Ratio |
1.24% |
1.42% |
| ||
Quick ratio |
0.56% |
0.46% |
| ||
Doom's day ratio |
0.07% |
0.13% |
| ||
Cash Flow to Debt |
1.89% |
2.94% |
| Leverage Ratios | ||
| ||
Leverage ratio |
2.23% |
2.19% |
| ||
Interest Coverage Ratio |
1.64% |
1.69% |
| ||
Debt to equity |
117.62% |
114.04% |
| ||
Debt to total assets |
0.41% |
0.39% |
| ||
Long Term Debt to Capital |
0.28% |
0.33% |
| ||
Debt / Enterprise Value |
0.51% |
0.48% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
4.26 |
9.31 |
| ||
Price/Book Ratio |
0.52 |
0.51 |
| ||
Market Cap / Net cash |
21.34 |
7.01 |
| ||
Market cap/Shareholder equity |
0.66 |
0.64 |
| Trend Ratios | ||
| ||
Revenue Trend |
0.79% |
|
| ||
Net Income Trend |
0.78% |
0.86% |
| ||
Operating Income Trend |
0.76% |
0.78% |
| ||
 |